Study Evaluating Venlafaxine ER in Patients With Panic Disorder
Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the efficacy, safety, and tolerability of venlafaxine
extended release (ER) capsules in the treatment of outpatients with panic disorder (PD) in
comparison to those of placebo.